Sponsors

Innovation in sepsis management: rapid POC host response testing

Sepsis is a life-threatening reaction to an infection, resulting in the immune system overreacting and the beginning of damage to the body’s own tissues and organs. Here, Charlotte Duncan introduces the latest in point-of-care technology.

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection.1 According to The UK Sepsis Trust, 250,000 people per year are affected by sepsis, of which 52,000 people die and 60,000 people suffer permanent, life-changing after effects.2 The often quoted aphorism that sepsis kills more people in the UK than bowel, breast and prostate cancer combined3 rather poignantly gives a sense of the scale of the problem.

                Indeed, the global picture is even more grim with sepsis causing an estimated 11 million deaths each year, and data showing those in vulnerable groups and low-resource settings account for 85% of these cases.4 In May 2017, the World Health Organization (WHO) issued a resolution confirming sepsis is a worldwide issue.5

                Given the significant disease burden in the UK, and globally, the diagnostic support to clinicians is lacking.6 Routine tests such as C-reactive protein (CRP), blood count, lactate7 and procalcitonin8 offer limited information on the inflammatory response of the patient in the form of ‘point-in-time’ assessments, requiring serial testing to obtain an indication of response to treatment, while most innovation focuses on bloodstream infections and subsequent identification and antimicrobial susceptibility testing (AST). Identification of a pathogen can allow clinicians to optimise antimicrobial therapy. Depending on the identification and AST result of an infecting organism, escalation or de-escalation of antibiotics and adjusting modes of administration can result in improved patient care9 and outcome, and support antimicrobial stewardship.10

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024